

Cover Story
FreeGuest Editorial
As I look through just-published tables of age-adjusted cancer mortality, I recognize an unprecedented development:
By Alexandria Carolan
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets


Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
- CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
- J. Craig Venter’s work was foundational to cancer advancement of the past 25 years
- Trump changes pick for Surgeon General, nominating Nicole Saphier
















